Literature DB >> 7791753

The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max.

R Hopewell1, E B Ziff.   

Abstract

Heterodimerization of Max with the nuclear oncoprotein Myc and the differentiation-associated proteins Mad and Mxi1 enables these factors to bind E-box sites in DNA and control genes implicated in cell proliferation and differentiation. We show that in the PC12 pheochromocytoma tumor cell line, functional Max protein is not expressed because of the synthesis of a mutant max transcript. This transcript encodes a protein incapable of homo- or heterodimerization. Furthermore, the mutant Max protein, unlike wild-type Max, is incapable of repressing transcription from an E-box element. Synthesis of mutant max transcripts appears to be due to a homozygous chromosomal alteration within the max gene. Reintroduction of max into PC12 cells results in repression of E-box-dependent transcription and a reduction in growth rate, which may explain the loss of Max expression either during the growth of the pheochromocytoma or in subsequent passage of the PC12 cell line in vitro. Finally, the ability of these cells to divide, differentiate, and apoptose in the absence of Max demonstrates for the first time that these processes can occur via Max- and possibly Myc-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791753      PMCID: PMC230583          DOI: 10.1128/MCB.15.7.3470

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  Structural analysis of the chicken max gene.

Authors:  K G Sollenberger; T L Kao; E J Taparowsky
Journal:  Oncogene       Date:  1994-02       Impact factor: 9.867

2.  Repression of cyclin D1: a novel function of MYC.

Authors:  A Philipp; A Schneider; I Väsrik; K Finke; Y Xiong; D Beach; K Alitalo; M Eilers
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

3.  Binding and suppression of the Myc transcriptional activation domain by p107.

Authors:  W Gu; K Bhatia; I T Magrath; C V Dang; R Dalla-Favera
Journal:  Science       Date:  1994-04-08       Impact factor: 47.728

4.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

5.  Nerve growth factor has both mitogenic and antimitogenic activity.

Authors:  D E Burstein; L A Greene
Journal:  Dev Biol       Date:  1982-12       Impact factor: 3.582

6.  c-Myc does not require max for transcriptional activity in PC-12 cells.

Authors:  V Ribon; T Leff; A R Saltiel
Journal:  Mol Cell Neurosci       Date:  1994-06       Impact factor: 4.314

7.  Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells.

Authors:  M E Greenberg; L A Greene; E B Ziff
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

8.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

9.  c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II.

Authors:  L H Li; C Nerlov; G Prendergast; D MacGregor; E B Ziff
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

10.  The N-Myc oncoprotein is associated in vivo with the phosphoprotein Max(p20/22) in human neuroblastoma cells.

Authors:  A Wenzel; C Cziepluch; U Hamann; J Schürmann; M Schwab
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  25 in total

1.  Essential role for Max in early embryonic growth and development.

Authors:  H Shen-Li; R C O'Hagan; H Hou; J W Horner; H W Lee; R A DePinho
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

Review 2.  Transcription-independent functions of MYC: regulation of translation and DNA replication.

Authors:  Michael D Cole; Victoria H Cowling
Journal:  Nat Rev Mol Cell Biol       Date:  2008-08-13       Impact factor: 94.444

Review 3.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 4.  Control of vertebrate development by MYC.

Authors:  Peter J Hurlin
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 5.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

Review 6.  Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis.

Authors:  Daniel Diolaiti; Lisa McFerrin; Patrick A Carroll; Robert N Eisenman
Journal:  Biochim Biophys Acta       Date:  2014-05-22

7.  MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer.

Authors:  Arnaud Augert; Haritha Mathsyaraja; Ali H Ibrahim; Brian Freie; Michael J Geuenich; Pei-Feng Cheng; Sydney P Alibeckoff; Nan Wu; Joseph B Hiatt; Ryan Basom; Adi Gazdar; Lucas B Sullivan; Robert N Eisenman; David MacPherson
Journal:  Cancer Cell       Date:  2020-05-28       Impact factor: 31.743

8.  Sin3b interacts with Myc and decreases Myc levels.

Authors:  Pablo Garcia-Sanz; Andrea Quintanilla; M Carmen Lafita; Gema Moreno-Bueno; Lucia García-Gutierrez; Vedrana Tabor; Ignacio Varela; Yuzuru Shiio; Lars-Gunnar Larsson; Francisco Portillo; Javier Leon
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

Review 9.  Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis.

Authors:  Charlotte Lussey-Lepoutre; Alexandre Buffet; Aurélie Morin; Judith Goncalves; Judith Favier
Journal:  Cell Tissue Res       Date:  2018-02-09       Impact factor: 5.249

Review 10.  Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.

Authors:  Svenja Nölting; Ashley B Grossman
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.